In this video, Xavier Robinson, founder and portfolio manager at Abrax merger arbitrage fund, reveals his outlook for the Swiss M&A market and his top late-stage merger investment bets. 

Speaking in April at the latest Appletree conference run by Alexandre Toussaint in Geneva, Robinson discusses what part of the cycle we are in at the moment and what to watch in the coming months in the merger arbitrage space. 

Here, he assesses the latest thematic trends, including consolidation in the technology, pharma and the biotech sectors in the US and reveals what the Trump administration could mean for the future of M&A activity.